Founders Capital Management (Texas)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $64.7K | Hold |
512
| – | – | 0.03% | 133 |
|
|
2026
Q1 | $71.4K | Sell |
512
-300
| -37% | -$42K | 0.03% | 115 |
|
|
2025
Q4 | $99.7K | Hold |
812
| – | – | 0.05% | 88 |
|
|
2025
Q3 | $90.1K | Hold |
812
| – | – | 0.05% | 91 |
|
|
2025
Q2 | $90K | Sell |
812
-200
| -20% | -$21.3K | 0.05% | 90 |
|
|
2025
Q1 | $113K | Hold |
1,012
| – | – | 0.07% | 72 |
|
|
2024
Q4 | $93.5K | Hold |
1,012
| – | – | 0.06% | 83 |
|
|
2024
Q3 | $84.8K | Hold |
1,012
| – | – | 0.05% | 92 |
|
|
2024
Q2 | $69.4K | Hold |
1,012
| – | – | 0.05% | 109 |
|
|
2024
Q1 | $74.1K | Hold |
1,012
| – | – | 0.05% | 111 |
|
|
2023
Q4 | $82K | Hold |
1,012
| – | – | 0.06% | 97 |
|
|
2023
Q3 | $75.8K | Hold |
1,012
| – | – | 0.06% | 94 |
|
|
2023
Q2 | $78K | Hold |
1,012
| – | – | 0.06% | 107 |
|
|
2023
Q1 | $84K | Hold |
1,012
| – | – | 0.06% | 99 |
|
|
2022
Q4 | $87K | Sell |
1,012
-100
| -9% | -$7.92K | 0.07% | 95 |
|
|
2022
Q3 | $69K | Hold |
1,112
| – | – | 0.06% | 106 |
|
|
2022
Q2 | $69K | Buy |
1,112
+112
| +11% | +$6.93K | 0.05% | 106 |
|
|
2022
Q1 | $73K | Hold |
1,000
| – | – | 0.05% | 101 |
|
|
2021
Q4 | $73K | Hold |
1,000
| – | – | 0.05% | 101 |
|
|
2021
Q3 | $70K | Hold |
1,000
| – | – | 0.05% | 101 |
|
|
2021
Q2 | $69K | Hold |
1,000
| – | – | 0.05% | 104 |
|
|
2021
Q1 | $65K | Buy |
1,000
+100
| +11% | +$6.45K | 0.05% | 96 |
|
|
2020
Q4 | $52K | Buy |
+900
| New | +$54.3K | 0.04% | 100 |
|
|
2020
Q1 | $67K | Buy |
900
+300
| +50% | +$20.7K | 0.07% | 74 |
|
|
2019
Q4 | $39K | Hold |
600
| – | – | 0.03% | 128 |
|
|
2019
Q3 | $38K | Hold |
600
| – | – | 0.03% | 128 |
|
|
2019
Q2 | $41K | Hold |
600
| – | – | 0.04% | 127 |
|
|
2019
Q1 | $39K | Buy |
600
+200
| +50% | +$13.3K | 0.04% | 131 |
|
|
2018
Q4 | $25K | Hold |
400
| – | – | 0.03% | 152 |
|
|
2018
Q3 | $31K | Hold |
400
| – | – | 0.03% | 144 |
|
|
2018
Q2 | $28K | Hold |
400
| – | – | 0.02% | 153 |
|
|
2018
Q1 | $30K | Hold |
400
| – | – | 0.03% | 174 |
|
|
2017
Q4 | $29K | Hold |
400
| – | – | 0.02% | 178 |
|
|
2017
Q3 | $32K | Hold |
400
| – | – | 0.03% | 162 |
|
|
2017
Q2 | $28K | Buy |
400
+100
| +33% | +$6.65K | 0.02% | 174 |
|
|
2017
Q1 | $20K | Buy |
+300
| New | +$21.1K | 0.02% | 207 |
|
Other funds holding GILD
Founders Capital Management (Texas)'s GILD Position: Q2 2026 in Review
Founders Capital Management (Texas) held its Gilead Sciences (GILD) position steady in Q2 2026 at 512 shares worth $64.7K. The position accounts for 0.03% of the portfolio, ranked #133.
Founders Capital Management (Texas) first reported a position in GILD in Q1 2017 and has held it in 36 quarters since. The position peaked at $113K in Q1 2025. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Founders Capital Management (Texas) held 512 shares of Gilead Sciences worth $64.7K as of Q2 2026.
- Founders Capital Management (Texas) left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up 0.03% of Founders Capital Management (Texas)'s portfolio in Q2 2026, its #133 holding.
- Founders Capital Management (Texas) first reported a position in Gilead Sciences in Q1 2017 and has held it in 36 quarters since.
- Founders Capital Management (Texas)'s Gilead Sciences position peaked at $113K in Q1 2025.
- 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Founders Capital Management (Texas)'s 13F filing for Q2 2026, filed 21 Jul 2026.